CDIX · XBRL financial data
Cardiff Lexington financial statements, every fiscal year
The same tables from 10 filings, lined up. Matched by XBRL tag: renamed lines keep their history.
How these numbers work
- Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
- Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
- * marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
- 0 means a filing states zero; a dash (—) means no filing states that number.
- “year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
- Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
- Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
- Shares outstanding come from each filing's cover page, as of the date printed there.
- Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.
Income statement
CSVFiscal years (CDIX's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 3,453 | 10,009 | 11,998 | 11,853 | 8,270 | 11,536 |
| Cost of revenue | 1,668 | 3,848 | 4,457 | 3,561 | 3,842 | 4,329 |
| Gross profit | 1,785 | 6,160 | 7,541 | 8,293 | 4,428 | 7,206 |
| Selling, general and administrative | 3,588 | 4,520 | 3,734 | 3,077 | 4,064 | 5,333 |
| Total operating expenses | 3,589 | 4,534 | 5,849 | 3,098 | 4,622 | 6,106 |
| Operating income (loss) | (1,804) | 1,626 | 1,692 | 5,195 | (194) | 1,101 |
| Interest expense | 144 | — | 453 | 440 | 3,046 | 6,823 |
| Other income (expense) | — | — | — | — | (5) | (22) |
| Income tax expense (benefit) | — | — | — | — | — | 0 |
| Net income (loss) | (2,837) | (410) | (5,430) | 3,028 | (3,303) | (5,508) |
| Earnings per share, basic USD per share | — | (0.01) | — | — | — | — |
| Earnings per share, diluted USD per share | — | (0.01) | — | — | — | — |
| Weighted average shares, basic thousands of shares | 908 | 128,022 | 436,637 | 14 | 11,443 | 6,928 |
| Weighted average shares, diluted thousands of shares | 908 | 128,022 | 6 | 15 | 11,443 | 8,499 |
- † Share count changed about 4x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/105 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Balance sheet
CSVFiscal years (CDIX's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 279 | 596 | 227 | 867 | 1,188 | 319 |
| Accounts receivable | 16 | 4,949 | 6,605 | 13,305 | 15,934 | 22,071 |
| Prepaid and other current assets | 0 | 5 | 5 | 5 | 90 | 204 |
| Total current assets | 296 | 5,550 | 6,837 | 14,177 | 17,213 | 22,593 |
| Property and equipment, net | 212 | 259 | 55 | 35 | 21 | 3 |
| Right-of-use asset | 53 | 284 | 219 | 289 | 407 | 215 |
| Goodwill | 3,500 | 4,484 | 5,667 | 5,667 | 5,667 | 5,667 |
| Total assets | 4,930 | 11,160 | 13,353 | 20,746 | 23,926 | 29,087 |
| Accounts payable | 120 | 171 | 342 | 721 | 684 | 1,091 |
| Current portion of long-term debt | 948 | — | — | — | — | — |
| Total current liabilities | 13,403 | 8,114 | 9,974 | 13,861 | 15,887 | 25,832 |
| Lease liability, non-current | 0 | 122 | 85 | 119 | 186 | 43 |
| Total liabilities | 13,802 | 8,379 | 10,198 | 14,124 | 16,324 | 26,014 |
| Accumulated deficit | (65,583) | (66,195) | (70,855) | (68,684) | (72,949) | (79,491) |
| Total stockholders' equity | (8,872) | 2,781 | (1,470) | 731 | 2,685 | (2,470) |
| Total liabilities and equity | 4,930 | 11,160 | 13,353 | 20,746 | 23,926 | 29,087 |
| Common shares outstanding (cover page) thousands of shares | 109,945 | 232,797 | 908,479 | 8,664 | 15,326 | 15,159 |
- † Share count changed about 4x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/105 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Cash flows
CSVFiscal years (CDIX's year ends in late December)
| In thousands of dollars | Dec 31, 2020 | Dec 31, 2021 | †Dec 31, 2022 | †Dec 31, 2023 | Dec 31, 2024 | Dec 31, 2025 |
|---|---|---|---|---|---|---|
| Net income (loss) | (2,837) | (410) | (5,430) | 3,028 | (3,303) | (5,508) |
| Stock-based compensation | — | — | — | 0 | 545 | 754 |
| Depreciation and amortization | 23 | 35 | 23 | 21 | 13 | 6 |
| Net cash from operating activities | — | — | (1,151) | (1,721) | — | — |
| Purchases of property and equipment | 0 | 3 | 0 | — | — | — |
| Net cash from investing activities | — | (2,324) | 0 | — | — | — |
| Dividends paid | — | — | — | — | 100 | 50 |
| Net cash from financing activities | 1,150 | 3,677 | 789 | 2,369 | 2,976 | 1,984 |
- † Share count changed about 4x in the period ending 2022-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
- † Share count changed about 1/105 in the period ending 2023-12-31, likely a stock split with no split ratio in the XBRL data; figures before that column are not adjusted.
Compare with peers
SIC 8011 and related industry codes, similar size. Each row is the latest quarter reported.
How peers are chosen
- SIC 8011 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
- Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
- Runway shows only for companies burning cash with under $10B of public float.
- * marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
| Company | Cash ($K) | Revenue, quarter ($K) | Operating cash flow, quarter ($K) | Shares outstanding | Runway | Quarter |
|---|---|---|---|---|---|---|
| Cardiff Lexington | 218 | 2,160 | (652)* | 15.6M | 0.3 quarters | 10-QJun 30, 2026 |
| SBC Medical Group Holdings | 184,311 | 49,188 | 22,509* | 102.8M | — | 10-QJun 30, 2026 |
| Airsculpt Technologies | 18,824 | 42,900 | (1,238)* | 72.1M | 15.2 quarters | 10-QJun 30, 2026 |
| Starling Oncology | 41,094 | 161,282 | 11,940* | 101.9M | — | 10-QJun 30, 2026 |
Not investment advice. Not affiliated with the U.S. SEC.